Approval · Notice of Compliance 21476 · 2018
RAPAMUNE: Notice of Compliance 21476
Issued October 30, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21476
- Date
- October 30, 2018
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Reduction of the shelf life to 24 mont due to failure at the 30 month timepoint in long term stability data
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAPAMUNE | Not yet assigned | — |
Medicinal ingredients
- SIROLIMUS 1 MG per ML